CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Friday reported fiscal third-quarter profit of $27.5 million.
The Cincinnati-based company said it had net income of 64 cents per share. Earnings, adjusted for one-time gains and costs, were 55 cents per share.
The diagnostic test maker posted revenue of $84.8 million in the period.
Meridian Bioscience expects full-year earnings in the range of $1.01 to $1.05 per share, with revenue in the range of $245 million to $250 million.
Meridian Bioscience shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.